This year sees us hosting the fifth Ending Age-Related Diseases conference, and once again we are bringing you four action-packed days of aging research, rejuvenation biotechnology, and biotech investment.
A virtual event focused on healthy longevity
Join us on August 11-14 for what is sure to be an unmissable event for people interested in longer and healthier lives. The event will be virtual this year, which means everyone can join us without having to worry about flights or hotels.
As in previous years, we will be bringing together the leading experts in research, biotech investment, blockchain, and advocacy to give you the best overview of what is happening in this exciting field.
Early Bird tickets are available now
We are offering a lower early bird price on conference tickets until May 31st. Register now if you would like to take advantage of the discounted price to gain full access to all four days of the conference!
The ticket includes the following:
- $350 for a $50 discount
- Access to all four days of talks and discussion panels
- All on-demand content, which includes more talks and exclusive interviews
- Access to sponsor content
- Watch the conference videos for at least a month after at your own leisure
There is also a free ticket that gives access to the opening talk and keynotes and is ideal to get a high-level overview of the field. You can always upgrade from a free ticket later if you decide you would like to take a deeper dive.
Bringing together the leading experts in aging research and investment
George Church, Irina Conboy, Brian Kennedy and Vadim Gladyshev are just some of the key industry figures with us this year, and we will be announcing more in the coming weeks, so be sure to join us!
George Church, Ph.D.
Harvard Medical School - Professor of Genetics
Irina Conboy, Ph.D.
UC Berkeley Research - Assistant Professor of Bioengineering
Brian Kennedy, Ph.D.
National University Singapore - Professor of Biochemistry and Physiology
Vadim Gladyshev, Ph.D.
Harvard Medical School - Professor, Medicine, Harvard Medical School
Steve Horvath, Ph.D.
Altos Labs - Principal Investigator San Diego Institute of Science
Greg Fahy, Ph.D.
Intervene Immune - CSO
Kris Verburgh, M.D.
Free University of Brussels
Hanadie Yousef, Ph.D.
Juvena Therapeutics - CEO
Matthew O'Connor, Ph.D.
Cyclarity Therapeutics - CEO of Scientific Affairs
Alexandra Stolzing, Ph.D.
Loughborough University - Professor of Biogerontological Engineering
João Pedro de Magalhães, Ph.D.
University of Liverpool
Marco Quarta, Ph.D.
Rubedo Life Sciences - CEO
For more info, you can check out the list of speakers.
We look forward to virtually seeing you in August at what promises to be another amazing event. Make sure you register for the conference soon before ticket prices increase!
